Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05989412 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.

Study acronym: MOOD
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Oct 2027 → Mar 2028
See other at-risk trials from Erasmus Medical Center

Record History

  1. Trial status changed: Enrolling by Invitation → Active, Not Recruiting Primary completion pushed from Oct 2027 to Mar 2028 · Completion moved earlier from Oct 2028 to Mar 2028 · Secondary endpoints: details revised at 1 of 1 entry · 2 more Show 5 more changesShow less
    • Primary completion pushed from Oct 2027 to Mar 2028
    • Completion moved earlier from Oct 2028 to Mar 2028
    • Secondary endpoints: details revised at 1 of 1 entry
    • Publications: details revised at 17 of 18 entries
    • Eligibility criteria expanded, about 3 words
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation Study sites: 0 to 1 · Start date changed from estimate of Oct 2024 to Sep 1, 2024v4 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2024 to Sep 1, 2024
  3. Primary completion date: Sep 2026 to Oct 2027 Start date: Feb 1, 2024 to Oct 2024 · Completion date: Sep 2026 to Oct 2028 · Eligibility criteria expanded, about 4 words · 1 morev3 Show 4 more changesShow less
    • Start date: Feb 1, 2024 to Oct 2024
    • Completion date: Sep 2026 to Oct 2028
    • Eligibility criteria expanded, about 4 words
    • Study description expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Sep 1, 2023 to Feb 1, 2024 Primary endpoint revised · Enrollment target: 1575 to 1786 · Secondary endpoints: details revised at 1 of 1 entry · 2 morev2 Show 5 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 1575 to 1786
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description expanded, about 124 words
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Major depressive disorder (MDD) is a mental disorder leading to a variety of emotional and physical problems affecting almost 300 million people worldwide. Long-term treatments for MDD, including medication and therapy, imposes a significant financial burden on society. Mobile-based screening interventions might be a promising approach for effectively reducing MDD symptoms. The investigators hypothesize that the mobile-based screening strategy evaluated in this proposal will substantially reduce the burden of MDD over time, increase participants' quality of life, and decrease MDD-related disparities
Trial Details
NCT Number NCT05989412
Lead Sponsor Erasmus Medical Center
Conditions Major Depressive Disorder
Enrollment 1,786 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov